What do Founders worry about?
Reflections on CogX Founder Roundtable
A computing impasse – the investments we make now will define our future
Brytlyt raises $5m to continue its impressive growth in the Real-Time Data Analytics Sector
What's happening in biotech?
On not downclimbing – the prospects for early stage biotech remain bright
Bringing immuno-oncology cell therapies to the masses – are we (nearly) there yet?
Will the boom last?
A window to the past: is the investment boom in biotech going to last?
On the UK biotech public market
Over the Hill and (still) far away for UK biotechs
Why you should consider manufacturing from the start of the biotech R&D process
Are you looking for advice from an experienced #deeptech investor?